| 000 | 01606 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512023125.0 | ||
| 264 | 0 | _c19860709 | |
| 008 | 198607s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/0024-3205(86)90207-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFlaim, K E | |
| 245 | 0 | 0 |
_aRegulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566. _h[electronic resource] |
| 260 |
_bLife sciences _cJun 1986 |
||
| 300 |
_a2087-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xmetabolism |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
| 650 | 0 | 4 | _aFenoldopam |
| 650 | 0 | 4 |
_aGuanosine Triphosphate _xpharmacology |
| 650 | 0 | 4 |
_aGuanylyl Imidodiphosphate _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLithium _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembranes _xmetabolism |
| 650 | 0 | 4 |
_aPotassium _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 |
_aSodium _xmetabolism |
| 700 | 1 | _aGessner, G W | |
| 700 | 1 | _aCrooke, S T | |
| 700 | 1 | _aHeys, J R | |
| 700 | 1 | _aWeinstock, J | |
| 773 | 0 |
_tLife sciences _gvol. 38 _gno. 23 _gp. 2087-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0024-3205(86)90207-9 _zAvailable from publisher's website |
| 999 |
_c2878413 _d2878413 |
||